These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 6431379
21. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V. J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989 [Abstract] [Full Text] [Related]
23. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens. Ullmann U, Lindemann B. Arzneimittelforschung; 1980 Oct; 30(8):1247-9. PubMed ID: 6776966 [Abstract] [Full Text] [Related]
24. [In vitro activity of fosfomycin]. Ceruti T, Biazzi E, D'Avossa I, Pennacchio A, Santini F. Arch Sci Med (Torino); 1980 Oct; 137(2):221-4. PubMed ID: 7224844 [Abstract] [Full Text] [Related]
27. [Phenotypes of resistance to antibiotics of the most frequently isolated strains in five specialized hospital centers. Multicenter study]. Gabastou JM, Chouaki T, Mangeot J, Zemir A, Manuel C, Lepitre M, Gravisse J, Cornel E, Denis-Jacquot N, Mahuzier G. Pathol Biol (Paris); 1995 Apr; 43(4):320-3. PubMed ID: 7567123 [Abstract] [Full Text] [Related]
29. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin. Gilbert DN, Kohlhepp SJ, Slama KA, Grunkemeier G, Lewis G, Dworkin RJ, Slaughter SE, Leggett JE. Antimicrob Agents Chemother; 2001 Mar; 45(3):883-92. PubMed ID: 11181375 [Abstract] [Full Text] [Related]
31. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]. Yang QW, Xu YC, Chen MJ, Hu YJ, Ni YX, Sun JY, Yu YS, Kong HS, He L, Wu WY, Ye HF, Yang YM, Zhu LN, Guo SH, Ji P, Zhu ZH, Ren JK, Zhang LX, Sun ZY, Zhu XH, Tong MQ, Zhao WS, Mei YN, Liu Y, Zhang ZJ, Duan Q, Li D, Liu PP, Wang J, Han LX, Wang H, Xie XL. Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2753-8. PubMed ID: 18167265 [Abstract] [Full Text] [Related]
34. [Sensitivity of bacteria causing urinary tract infections towards terizidon (author's transl)]. Wewalka G, Rotter M, Fischer A. Wien Klin Wochenschr; 1976 May 28; 88(11):355-60. PubMed ID: 826024 [Abstract] [Full Text] [Related]
35. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates. Skar AG, Midtvedt T, Dahl O. NIPH Ann; 1984 Jun 28; 7(1):13-9. PubMed ID: 6493580 [Abstract] [Full Text] [Related]
36. [Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin]. Lindenschmidt EG, Schassan HH. Immun Infekt; 1980 Jun 28; 8(4):121-6. PubMed ID: 6453080 [Abstract] [Full Text] [Related]
37. Nation-wide survey of antibiotic resistance by means of a computer: bacterial strains from the urine, stool, and upper respiratory tract. Krcméry V, Grunt J. Zentralbl Bakteriol Orig A; 1975 Sep 28; 233(1):99-105. PubMed ID: 812295 [Abstract] [Full Text] [Related]
38. Antimicrobial activity of fosfomycin in vitro. Forsgren A, Walder M. J Antimicrob Chemother; 1983 May 28; 11(5):467-71. PubMed ID: 6874631 [Abstract] [Full Text] [Related]
39. [Preliminary study of the antagonistic effects between fosfomycin and beta-lactams on Pseudomonas aeruginosa observed on the antibiogram]. Buisson Y, Bercion R, Mauclère P, Hugard L, Schill H. Pathol Biol (Paris); 1988 Jun 28; 36(5 Pt 2):671-4. PubMed ID: 3141886 [Abstract] [Full Text] [Related]
40. [Investigations on the antibacterial activity of fosfomycin on DST-agar (author's transl)]. Hirschl A, Rotter M, Maruna H. Zentralbl Bakteriol Orig A; 1978 Dec 28; 242(4):537-46. PubMed ID: 749420 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]